Mary M. Horowitz

发表

Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning.

J. Wingard, G. Socié, R. Sobecks, 2010, Blood.

Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.

M. Horowitz, D. Vesole, C. Bredeson, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry.

Loren Gragert, Martin Maiers, Mary Horowitz, 2014, The New England journal of medicine.

Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia

A. Gratwohl, P. Ljungman, K. Sobocinski, 1998, Bone Marrow Transplantation.

Salvage haploidentical hematopoietic cell transplantation for graft rejection following a prior haploidentical allograft

P. Hari, M. Pasquini, M. Horowitz, 2017, Bone Marrow Transplantation.

Exercise and stress management training prior to hematopoietic cell transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902.

N. Geller, W. Wood, H. Jim, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide.

M. Horowitz, K. Ballen, C. Bredeson, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Graft-versus-leukemia reactions in humans. The Advisory Committee of the International Bone Marrow Transplant Registry.

M. Horowitz, O. Ringdén, Mary M. Horowitz, 1989, Transplantation proceedings.

Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS).

J. Cortes, M. Horowitz, M. Kalaycio, 2013, Blood.

Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning.

D. Weisdorf, M. Arora, M. Eapen, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Centralized patient‐reported outcome data collection in transplantation is feasible and clinically meaningful

A. Abernethy, M. Horowitz, Stephanie J. Lee, 2017, Cancer.

Modelling covariate adjusted mortality relative to a standard population.

J. V. Stone, J. Klein, Per Kragh Andersen, 1999, Statistics in Medicine.

Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric population

R. Collins, D. Porter, A. Barrett, 2008, Bone Marrow Transplantation.

Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study.

P. Westervelt, A. Alousi, R. Maziarz, 2023, Bone marrow transplantation.

Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).

Alan M. Miller, J. Armitage, J. Vose, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States.

J. Klein, M. Horowitz, Stephanie J. Lee, 2005, Blood.